Saitta, Kyle S.. The role of the group I metabotropic glutamate receptor agonist, CHPG, in oligodendrocyte regeneration and repair following a cuprizone-induced lesion. Retrieved from https://doi.org/doi:10.7282/t3-fsm6-tz70
TitleThe role of the group I metabotropic glutamate receptor agonist, CHPG, in oligodendrocyte regeneration and repair following a cuprizone-induced lesion
DescriptionDemyelinating diseases or demyelination in response to toxic agents can be debilitating to patients and can greatly impair the quality of life. Therefore, new therapeutic targets are needed that enhance the regeneration and repair of oligodendrocytes, the myelin-producing cells. In an effort to identify drugs that delay demyelination and promote remyelination, previous work from our lab has been evaluating effects of metabotropic glutamate receptor (mGluR) agonists. The current work assesses the role of one such agonist, 2-chloro-5-hydroxyphenylglycine (CHPG), in the cuprizone model of demyelination in mice. Peripheral injection of CHPG was found to work within the lesion site to influence myelination.